On-Demand Webinars

  1. Breaking The Concentration Barrier: New Long-Term Stability And PK Data For Subcutaneous Nanotrastuzuma 9/22/2026

    Nanoparticle engineering enabled a 440 mg/mL trastuzumab suspension that clears viscosity and stability barriers limiting conventional high-dose subcutaneous biologics formulations.

  2. Unlocking Challenging Targets With Macrocycle DNA-Encoded Libraries 9/22/2026

    Discover how macrocycle DNA-encoded libraries can uncover new opportunities for challenging targets and help researchers translate promising screening hits into starting points for drug discovery.

  3. Breaking The AAV Titer Barrier: A 9x Manufacturing Breakthrough 9/22/2026

    See how targeted optimization of cell culture media and transfection reagents increased AAV titers ninefold while improving full capsid percentages, strengthening HEK293 production, and more.

  4. Beyond The Starting Material: A Path To GMP Manufacturing Success 9/21/2026

    Explore how starting material decisions affect cell therapy development, tech transfer, and GMP readiness, as well as practical guidance for aligning material requirements with manufacturing processes.

  5. Building Oral Dosage Forms for Speed Today And Success Tomorrow 9/18/2026

    Move toward the clinic with confidence using integrated development strategies that support smarter decisions and more efficient product development.

     

  6. Improving Clinical Translation For ADCs And Immuno-Oncology With Human-Relevant Tumor Models 9/17/2026

    When preclinical tumor models fail to reflect clinical reality, promising therapies pay the price. This webinar examines how advanced patient-derived organoids and 3D models improve predictive accuracy for ADC and immuno-oncology programs.

  7. A Smarter Microbial Approach To Therapeutic Peptide Manufacturing 9/17/2026

    See how microbial expression can improve therapeutic peptide yields, reduce costs, and simplify downstream processing while supporting development from research through manufacturing.

  8. Establishing A Risk-Based Containment Strategy For High-Potency Micronization 9/16/2026

    This session presents a risk-based framework for high-potency micronisation, illustrated through a practical case study that spans development to commercial scale.

  9. A New Chapter for Orexin Therapies: What's Changing in Drug Development 9/16/2026

    Join Beatrice Setnik, PhD and Denise Milova, PhD, for a conversation on orexin rescheduling and the evolving regulatory landscape.

  10. Scaling AAV Manufacturing To 1000 L: Strategies For Robust Production 9/15/2026

    Learn how integrated cell line, media, and process design can support consistent AAV production at larger volumes while maintaining productivity and quality, as well as reducing scale-up risk.